Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.

Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150

Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: Results from a randomized, phase III, factorial trial (TRISST).

Joffe JK. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39

Real-world outcomes in patients receiving neo-adjuvant chemotherapy for early-stage breast cancer

McDonald C. et al, (2021), CANCER RESEARCH, 81

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.

Turner NC. et al, (2020), Lancet Oncol, 21, 1296 - 1308

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Hudeček J. et al, (2020), npj Breast Cancer, 6

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Kos Z. et al, (2020), NPJ Breast Cancer, 6

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Amgad M. et al, (2020), NPJ Breast Cancer, 6

Results from plasmaMATCH: a multiple parallel cohort, multi-centre clinical trial of circulating tumour DNA testing to direct targeted therapies in patients with advanced breast cancer

Ring A. et al, (2020), BREAST CANCER RESEARCH AND TREATMENT, 180, 531 - 531

Improvements in long-term outcome for women with estrogen receptor positive (ER plus ) early stage breast cancer treated with 5 years of endocrine therapy: Analyses of 82,598 women in the Early Breast Cancer Trialists' Collaborative Group (EBCTCG) database

Pan H. et al, (2020), CANCER RESEARCH, 80

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Kos Z. et al, (2020), NPJ Breast Cancer, 6

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Amgad M. et al, (2020), NPJ Breast Cancer, 6

Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future

Robinson T. et al, (2020), Clinical Oncology

Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery

Wilson TG. et al, (2020), Clinical Oncology

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452

Stage 1 Testicular Seminomas Treated with Single Cycle Carboplatin: Outcomes and Management of Relapse: A Single-Centre Experience

Kirk H. et al, (2018), INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 102, E153 - E153

Stereotactic radiosurgery (SRS) for brain metastases (BM) from breast cancer (BC): A single centre experience of factors influencing survival

Wilson T. et al, (2018), ANNALS OF ONCOLOGY, 29, 117 - 117

Management and outcomes of stage 2a testicular seminoma: a single-centre experience

Kirk H. et al, (2018), CLINICAL ONCOLOGY, 30, E3 - E3

18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.

Hall DO. et al, (2018), Nucl Med Commun, 39, 161 - 170

Increasing the dose density of adjuvant chemotherapy by shortening intervals between courses or by sequential drug administration significantly reduces both disease recurrence and breast cancer mortality: An EBCTCG meta-analysis of 21,000 women in 16 randomised trials

Gray R. et al, (2018), CANCER RESEARCH, 78

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2018), Lancet Oncol, 19, 27 - 39

Load More

Include forthcoming?